Arrowhead Research | ARWR - Sales Revenues


Arrowhead Research reported $264.03M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agios Pharmaceuticals USD 12.9M 450K Sep/2025
Alnylam Pharmaceuticals USD 1.25B 476.31M Sep/2025
Arrowhead Research USD 264.03M 7.56M Dec/2025
Incyte USD 1.37B 310M Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
Ligand Pharmaceuticals USD 115.46M 67.83M Sep/2025
Merck USD 16.4B 880M Dec/2025
Moderna USD 1.02B 878M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Sarepta Therapeutics USD 399.4M 211.69M Sep/2025
TG Therapeutics USD 161.7M 20.6M Sep/2025
Ultragenyx Pharmaceutical USD 160M 6.5M Sep/2025
Vertex Pharmaceuticals USD 3.08B 120M Sep/2025
Xencor USD 21M 22.61M Sep/2025